supportive and pivotal data needed to establish the effectiveness
of chloramine-T to control mortality caused by certain bacterial
|Source of drug:
Western Chemical Inc.
||1269 Lattimore Road
Ferndale, WA 98248 USA
Greenville, MS 38701-7505
Toll Free: 800-283-5292 ext 4175
flavobacteriosis (e.g., bacteria responsible for bacterial gill disease and external
flow-through or standing-bath treatment
10, 15 or 20 mg/L for BGD and external columnaris in cold, cool and warmwater fish.
60 minutes per day for up to 3 days.
Fish may be released or harvested for market immediately following
must collect mortality data throughout the 5-day pre-treatment,
treatment, and 14-day post-treatment periods. Investigator should
also report general fish behavior and any adverse effects relating
or restrictions on use:
Not for use on fish in culture systems with no outflows .
must follow all instructions in the Study Protocol for INAD
9321 regarding drug acquisition and handling, fish treatment
and disposition, and data reporting requirements.
per facility per year
contact for other information:
Bonnie Johnson, FWS - AADAP
||Product and company names mentioned in this website, or mentioned in materials accessed via this website, are for informational purposes only. The mention of such does not imply endorsement by the Aquatic Animal Drug Approval Partnership, the U.S. Fish & Wildlife Service or any other organization of the U.S. Government.